Curated News
By: NewsRamp Editorial Staff
August 21, 2025
EVERMIND Holdings Engages Wellfleet for $2M+ Capital Raise Strategy
TLDR
- BFCH partners with Wellfleet Investments to secure funding for acquisitions and uplisting, creating potential asymmetric returns for shareholders in a disciplined turnaround.
- BFCH's two-phase capital raise involves a $150k seed for compliance and a $1.5M-$2M institutional round to scale assets after OTCQB uplisting.
- This strategic funding supports BFCH's focus on cognitive health and functional wellness, aiming to improve mental and physical well-being through innovation.
- A physician-led public company engages a veteran investment banker to fund its turnaround and expansion into cognitive health products.
Impact - Why it Matters
This development matters because it represents a rare case of an OTC-market company pursuing institutional-grade compliance and financing, which could signal a shift toward more legitimate investment opportunities in traditionally volatile markets. For investors, it offers potential exposure to the growing cognitive health and functional wellness sector through a structured turnaround with professional banking support. The company's focus on governance reforms and audit readiness addresses common concerns about OTC-listed companies, potentially reducing investment risk while creating a model for other micro-cap companies seeking credibility. The engagement of a registered broker-dealer like Wellfleet, with its $22 billion in investor connections, provides validation that could attract more institutional capital to the OTC space, benefiting both the company and the broader market.
Summary
BitFrontier Capital Holdings, Inc. (OTCID: BFCH), operating as EVERMIND Holdings, Inc., has engaged veteran investment banking firm Wellfleet Investments LLC to lead its strategic capital formation efforts. Wellfleet, a FINRA-registered broker-dealer established in New York in 1998 with deep institutional investor relationships, will support BFCH's two-phase capital raise plan. The company, led by physician CEO Dr. Jordan P. Balencic, is executing a disciplined turnaround strategy focused on cognitive health and functional wellness through its EVERMIND brand.
The capital strategy involves Phase I: a $150,000 seed raise to fund legal compliance, governance enhancements, formation of EVERMIND Labs, and finalization of the ERApeutics (d/b/a EVERMIND™ Beverage) acquisition, plus audit preparation and OTCQB uplisting readiness. Phase II will involve a $1.5M to $2M institutional raise upon successful completion of Phase I, with proceeds used to acquire additional assets and scale operations. The company has recently amended its Q2 Report and 2024 Management Certification on OTC Markets to reflect current management and strategy, demonstrating its commitment to transparency and compliance.
Dr. Balencic emphasized that securing a FINRA-registered investment banker at this stage is uncommon and validates their methodical approach to creating shareholder value. Jeffrey Bega, CEO of Wellfleet Investments, noted that BFCH's governance reset and asset strategy align with what smart capital seeks, highlighting the firm's role in connecting disciplined plans with family offices and institutional investors. Additional information about Wellfleet can be found through FINRA BrokerCheck and their official website.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, EVERMIND Holdings Engages Wellfleet for $2M+ Capital Raise Strategy
